405 related articles for article (PubMed ID: 32329507)
1. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
3. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of microRNA-25 in patients with non-small cell lung cancer in Chinese population: A systematic review and meta-analysis.
Li C; Sun L; Zhou H; Yang Y; Wang Y; She M; Chen J
Medicine (Baltimore); 2020 Dec; 99(51):e23425. PubMed ID: 33371070
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of microRNA-148/152 family in non-small-cell lung cancer (NSCLC): A systematic review and meta-analysis.
Cheng L; Li Q; Tan B; Ma D; Du G
Medicine (Baltimore); 2021 Dec; 100(48):e28061. PubMed ID: 35049226
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Lamichhane SR; Thachil T; De Ieso P; Gee H; Moss SA; Milic N
Dis Markers; 2018; 2018():8309015. PubMed ID: 30538784
[TBL] [Abstract][Full Text] [Related]
8. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer.
Yi M; Liao Z; Deng L; Xu L; Tan Y; Liu K; Chen Z; Zhang Y
Ann Med; 2021 Dec; 53(1):2178-2193. PubMed ID: 34913774
[TBL] [Abstract][Full Text] [Related]
9. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis.
Ren J; Kuang TH; Chen J; Yang JW; Liu YX
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):120-130. PubMed ID: 28121346
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.
Ma Y; Chen Y; Lin J; Liu Y; Luo K; Cao Y; Wang T; Jin H; Su Z; Wu H; Chen X; Cheng J
Oncotarget; 2017 Apr; 8(17):28660-28671. PubMed ID: 28404921
[TBL] [Abstract][Full Text] [Related]
12. The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis.
Huang H; Zhu J; Lin Y; Zhang Z; Liu J; Wang C; Wu H; Zou T
Expert Rev Mol Diagn; 2021 Aug; 21(8):823-836. PubMed ID: 34043929
[No Abstract] [Full Text] [Related]
13. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
14. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy.
Li LL; Qu LL; Fu HJ; Zheng XF; Tang CH; Li XY; Chen J; Wang WX; Yang SX; Wang L; Zhao GH; Lv PP; Zhang M; Lei YY; Qin HF; Wang H; Gao HJ; Liu XQ
Oncotarget; 2017 Jul; 8(28):45399-45414. PubMed ID: 28514730
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of MicroRNA-18a for Gastric Cancer: a Meta-Analysis.
Liang Q; Zhang G; Wang J; Sheng S
Clin Lab; 2018 Jan; 64(1):177-184. PubMed ID: 29479894
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas.
Xu TP; Zhu CH; Zhang J; Xia R; Wu FL; Han L; Shen H; Liu LX; Shu YQ
Asian Pac J Cancer Prev; 2013; 14(12):7085-90. PubMed ID: 24460255
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
He RQ; Cen WL; Cen JM; Cen WN; Li JY; Li MW; Gan TQ; Hu XH; Chen G
Cell Physiol Biochem; 2018; 46(3):925-952. PubMed ID: 29669324
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum miR-25 in non-small-cell lung cancer.
Li J; Yu M; Liu Z; Liu B
Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763
[No Abstract] [Full Text] [Related]
20. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
